FDA Inspection
DSC Laboratories, Inc.DSC Laboratories, Inc. – FDA Inspection, Jul 16, 2025
Record Details
This FDA Inspection record concerns DSC Laboratories, Inc., with an inspection on July 16, 2025, issued by the Detroit District Office, covering human drugs.
View Company Profile
ID · 32f839c6-ee96-4e7b-9e9f-6f4626283637
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1275862
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
6- 21 CFR 211.68(b)Computer control of master formula records
- 21 CFR 211.142(b)Storage under appropriate conditions
- 21 CFR 211.192Extent of discrepancy, failure investigations
- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.194(c)Testing and standardization of standards et. al.
- 21 CFR 211.166(a)Lack of written stability program
Full citation text and observation details available on the Dashboard.
Other FDA inspections of DSC Laboratories, Inc.
6| Date | Classification | Office | Project area |
|---|---|---|---|
| October 11, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 25, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 31, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 27, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 13, 2010 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for DSC Laboratories, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.